1298084-37-3

Basic information

• Product Name: 6-(6-(5-amino-2-methylphenyl)-1H-indole-1-yl)pyrimidine-4-amine
• Synonyms: 6-(6-(5-amino-2-methylphenyl)-1H-indole-1-yl)pyrimidine-4-amine
• CAS NO: 1298084-37-3
• Molecular Weight: 315.377
• Mol File: 1298084-37-3.mol

Chemical Properties

• CAS DataBase Reference: 6-(6-(5-amino-2-methylphenyl)-1H-indole-1-yl)pyrimidine-4-amine(CAS DataBase Reference)
• NIST Chemistry Reference: 6-(6-(5-amino-2-methylphenyl)-1H-indole-1-yl)pyrimidine-4-amine(1298084-37-3)
• EPA Substance Registry System: 6-(6-(5-amino-2-methylphenyl)-1H-indole-1-yl)pyrimidine-4-amine(1298084-37-3)

Safety Data

• Hazardous Substances Data: 1298084-37-3(Hazardous Substances Data)

Upstream product

• 957062-84-9 4,4,5,5-tetramethyl-2-(2-methyl-5-nitrophenyl)-1,3,2-dioxaborolane 
• 52415-29-9 6-bromo-1H-indole 
• 1298084-35-1 1-(6-chloropyrimidine-4-yl)-6-(2-methyl-5-nitrophenyl)-1H-indole 
• 1298084-34-0 6-(2-methyl-5-nitrophenyl)-1H-indole 
• 1298084-36-2 6-(6-(2-methyl-5-nitrophenyl)-1H-indole-1-yl)pyrimidine-4-amine 

Downstream Products

• 1298084-14-6 1-(3-(1-(6-aminopyrimidine-4-yl)-1H-indole-6-yl)-4-methylphenyl)-3-(2-methoxyphenyl)urea 

Relevant articles and documents

CML THERAPEUTIC AGENTS WITH REDUCED DRUG-RESISTANCE AND SIDE-EFFECT COMPRISING 1,6-DISUBSTITUTED INDOLE COMPOUNDS

The present invention relates to a therapeutic agent for chronic myelogenous leukemia with reduced drug-resistance and side-effects containing a 1,6-disubstituted indole compound.

NOVEL 1,6-DISUBSTITUTED INDOLE COMPOUNDS AS PROTEIN KINASE INHIBITORS

Disclosed are a 1,6-substituted indole compound having a protein kinase inhibition activity, a pharmaceutically acceptable salt, and a pharmaceutical composition for prevention and treatment of cancers caused by abnormal cell growth comprising the compoun

NOVEL 1,6-DISUBSTITUTED INDOLE COMPOUNDS AS PROTEIN KINASE INHIBITORS

Disclosed are a 1,6-substituted indole compound having a protein kinase inhibition activity, a pharmaceutically acceptable salt, and a pharmaceutical composition for prevention and treatment of cancers caused by abnormal cell growth comprising the compoun